Clinical trial
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
NCT07144137 is registered in ClinicalTrials.gov with Complement Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
- Lead sponsor
- Complement Therapeutics
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 30, 2025
- Completion date
- June 30, 2027
- Enrollment
- 75 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
geographic atrophy secondary to age-related macular degeneration